Marcus Okonkwo

Biography

Marcus Okonkwo leads the development of Unzyme's pharmaceutical enhancement products, including HaemoFlow X and the Endorphin Engine series. His expertise in targeted drug delivery has enabled the creation of enhancement compounds that work precisely where needed without systemic side effects. Before joining Unzyme, Okonkwo spent fifteen years in traditional pharmaceutical development, growing increasingly frustrated with the industry's conservative approach to human optimization. At Unzyme, he has found the freedom to pursue truly transformative research.